Daniel Heudobler

9PUBLICATIONS

51CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 19, 2026

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|May 31, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Feb 26, 2026

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Jan 28, 2026

Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.

Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop

|Jan 11, 2024

Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.

Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop

|Oct 23, 2023

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.

Andreas Mackensen, John B A G Haanen, Christian Koenecke

Pageof 2

Frequent Collaborators

Florian Lüke

Tobias Pukrop

Manuel Ruh

Farastuk Bozorgmehr

Dirk Jaeger

Carsten Reinhardt

Meike Hutt

Norbert Hilf

Heiko Becker

Martin Wermke

Frequent Collaborators

Florian Lüke

Tobias Pukrop

Manuel Ruh

Farastuk Bozorgmehr